Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum

Acta Tropica

Volumn 74, Issue 1, 2000, Pages 25-31

  Sereno, D ^a   Holzmuller, P ^a   Lemesre, J L ^a  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

Drug resistance; Leishmania; Sb(III) resistant amastigotes; Second line drugs

Indexed keywords

AMPHOTERICIN B; ANTIMONY TARTRATE; MEGLUMINE ANTIMONATE; PENTAMIDINE;

DRUG PRESCRIBING; LEISHMANIASIS;

AMASTIGOTE; ARTICLE; CELL LINE; CONTROLLED STUDY; CROSS RESISTANCE; DOSE RESPONSE; DRUG EFFICACY; DRUG RESISTANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEISHMANIA INFANTUM; MUTANT;

AMPHOTERICIN B; ANIMALS; ANTIMONY POTASSIUM TARTRATE; ANTIPROTOZOAL AGENTS; CELL LINE; DRUG RESISTANCE; HUMANS; LEISHMANIA INFANTUM; MEGLUMINE; MUTATION; ORGANOMETALLIC COMPOUNDS; PENTAMIDINE;

LEISHMANIA INFANTUM;

EID: 0033990918     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(99)00048-0     Document Type: Article

References (32)

1. Alvar J.C., Canavate B., Gutierrez-Solar M. et al. Leishmania and human immunodefieciency virus coinfections: the first 10 years. Clin. Microbiol. Rev. 10:1997;298-319.
2. Atkinson A.J., Benett J.E. Amphotericin B pharmacokinetics in humans. Antimicrob. Agents Chemother. 1:1978;271-276.
3. Bates P.A. Complete developmental cycle of Leishmania mexicana in axenic culture. Parasitology. 108:1992;1-9.
4. Bates P.A., Robertson C.D., Tetley L. et al. Cultivation and characterization of Leishmania mexicana amastigote-like forms. Parasitology. 105:1992;193-202.
5. Bates P.A. Axenic culture of Leishmania amastigotes. Parasitol. Today. 9:1993;143-146.
6. Berman J.D., Wyler D.J. An in vitro model for investigation of chemotherapeutic agents in leishmaniasis. J. Infect. Dis. 142:1981;83-86.
7. Berman J.D., Gallalee J.V., Hansen B.D. Leishmania mexicana: uptake of sodium stibogluconate (Pentostam) and pentamidine by parasite and macrophages. Exp. Parasitol. 64:1987;127-131.
8. Callahan H.L., Beverley S.M. Heavy metal resistance: a new role for P-glycoproteins in Leishmania. J. Biol. Chem. 266:1991;18424-18430.
9. Coombs G.H., Craft J.A., Hart D.T. A comparative study of Leishmania mexicana amastigotes and promastigotes. Enzyme activities and subcellular locations. Mol. Biochem. Parasitol. 5:1982;199-211.
10. Coombs G.H., Tetley L., Moss V.A. et al. Three-dimensional structure of the Leishmania amastigote as revealed by computer-aided reconstruction from serial sections. Parasitology. 92:1986;13-23.
11. Faraut-Gambarelli F., Piarroux R., Deniau M. et al. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis. Antimicrob. Agents Chemother. 41:1997;827-830.
12. Gebre-Hiwot A., Tadesse G., Croft S.L. et al. An in vitro model for screening antileishmanial drugs: the human leukemia monocyte cell line, THP-1. Acta Trop. 51:1992;237-245.
13. Grogl M., Thomason T.N., Franke E. Drug resistance in leishmaniasis: it's implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am. J. Trop. Med. Hyg. 47:1992;117-126.
14. Hassan H.F., Coombs G.H. Leishmania mexicana, purine metabolizing enzymes of amastigotes and promastigotes. Exp. Parasitol. 59:1985;15-28.
15. Jha T.K. Evaluation of diamidine compounds (pentamidine isethionate) in the treatment of resistant cases of kala-azar occuring in north Bihar, India. Trans. Roy. Soc.Trop. Med. Hyg. 77:1983;167-170.
16. Jha S.N., Singh N.P.K., Jha T.K. Changing responses to diamidine compounds in cases of visceral leishmaniasis unresponsive to antimonials. J. Assoc. Physicians India. 39:1991;314-316.
17. Lemesre, J.L., 1994. Methods for the culture in vitro of differents stages of tissue parasites. International publication No. WO 94/26899.
18. Lemesre J.L., Sereno D., Daulouede S. et al. Leishmania spp: Nitric oxide-mediated metabolic inhibition of promastigote and axenically-grown amastigote forms. Exp. Parasitol. 86:1997;58-68.
19. Ouellette M., Papadopoulou B. Mechanism of drug resistance in Leishmania. Parasitol. Today. 9:1993;150-153.
20. Ouellette M., Fase-Fowler F., Borst P. The amplified H circle of methotrexate-resistant Leishmania tarentolae contains a novel P-glycoprotein gene. EMBO J. 9:1990;195-291.
21. Papadopoulou B., Roy G., Dey S. et al. Contribution of the Leishmania P-glycoprotein-related gene ItpgpA to oxyanion resistance. J. Biol. Chem. 269:1994;11980-11986.
22. Peters B.S., Fish D., Golden R. et al. Visceral Leishmaniasis in HIV infection and AIDS: clinical feature and response to therapy. Quat. J. Med. 77:1990;1101-1111.
23. Rainey P.M., Spithill T.W., McMahon-Pratt D. et al. Biochemical and molecular characterization of Leishmania pifanoi amastigotes in continuous axenic culture. Mol. Biochem. Parasitol. 49:1991;111-118.
24. Russo R., Lanotte G., Serres E. et al. Visceral leishmaniasis in HIV-infected patients: treatment with high dose liposomal amphotericin B (Ambisome). J. Infect. 32:1996;133-137.
25. Sereno D., Lemesre J.L. Axenically cultured amastigote forms as an in vitro model for investigation of antileishmanial agents. Antimicrob Agents Chemother. 41:1997;972-976.
26. Sereno D., Lemesre J.L. In vitro life cycle of pentamidine-resistant amastigotes: stability of the chemoresistant phenotypes is dependent on the level of resistance induced. Antimicrob. Agents Chemother. 41:1997;1898-1903.
27. Sereno D., Lemesre J.L. Use of an enzymatic in vitro micromethod to quantify amastigote stage of axenically-grown amastigote forms of Leishmania amazonensis. Parasitol. Res. 83:1997;401-403.
28. Sereno D., Michon P., Brajon N. et al. Phenotypic characterization of Leishmania mexicana pentamidine-resistant promastigotes: modulation of the resistance during developmental life cycle. CR Acad. Sci. 320:1997;981-987.
29. Sereno D., Cavaleyra M., Zemzoumi K. et al. Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action. Antimicrob. Agents Chemother. 42:1998;3097-3102.
30. Tsuchiya S., Kobayashi Y., Goto Y. et al. Induction of maturation in cultured human monocytic leukemia cells by phorbol diester. Cancer Res. 42:1982;1530-1536.
31. Ullman B. Multidrug resistance and P-glycoproteins in parasitic protozoa. J. Bioenergetics Biomemb. 27:1995;77-84.
32. Waalkes T.P., Devita V.T. The determination of pentamidine (4-4′diaminodinophenoxypentane) in plasma, urine and tissues. J. Lab. Clin. Med. 75:1970;871-878.